Lisa Z. Sproat, M.D.

Location

Contact

SUMMARY

As a researcher, Lisa Z. Sproat, M.D., studies acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia. Her research also focuses on myelodysplastic syndrome and chronic myeloid leukemia. As a clinician, Dr. Sproat provides individualized care for patients with these diseases.

Focus areas

• Mutations in the FLT3 gene. Dr. Sproat is conducting a clinical trial for people with malignancies and FLT3 mutations. She is investigating whether an FLT3 inhibitor can help people who have an FLT3 mutation and certain conditions.

Significance to patient care

Currently, most acute leukemias are not cured by chemotherapy alone, and people must proceed to allogeneic stem cell transplants. The goal is to find improved targeted agents and chemotherapies that would induce cures and eliminate the need for allogeneic stem cell transplants.

Professional highlights

• Unparalleled Experience Award, Mayo Clinic in Arizona, 2019, 2020, 2022, 2023.
• Day Maker Recognition, Mayo Clinic in Arizona, 2021.
• Acute and Chronic Leukemia Program, Division of Hematology and Medical Oncology, and Blood and Marrow Transplant, Mayo Clinic in Arizona:
  • Clinical and research director, 2013-2020.
  • Director, 2013-2020.
  • Associate director, 2011-2013.
  • Clinical director, 2011-2013.
• Mayo Wow Appreciation Recognition, Mayo Clinic in Arizona, 2019.
• Outstanding faculty member, Mayo School of Continuous Professional Development for Arizona, Mayo Clinic College of Medicine and Science, Mayo Clinic, 2016.
• Recognition of leadership in the Arizona philanthropic community, Society of Chairs, 2014-2015.
• Top faculty member, Mayo School of Continuous Professional Development, Mayo Clinic College of Medicine, Mayo Clinic, 2012.